DASA announces extraordinary shareholder meeting

• Dasa will hold an extraordinary shareholders’ meeting in Barueri, São Paulo state on Aug. 3, 2026.
• Shareholders will vote on the proposed merger of Patologia Clínica Dr. Geraldo Lustosa Cabral into Dasa.
• The meeting will also consider appointing Apsis Consultoria e Avaliações as independent appraiser and approving its valuation report.
• The valuation sets the target’s net assets at BRL 16.22 million as of March 31, 2026, adjusted for lease-accounting items.
• Management will also seek authorization to complete steps required to implement the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DASA - Diagnósticos da América SA published the original content used to generate this news brief on August 03, 2026, and is solely responsible for the information contained therein.